Head to head
CrowdStrike vs Microsoft
Side-by-side on the measures that matter, with a plain-English read. Full detail: CRWD · MSFT
CRWD
CrowdStrike
275.04+4.57%
1-year price shape — +116% over the period
Quant Rating B · 95/100
vs
MSFT
Microsoft
535.07+2.38%
1-year price shape — +3% over the period
Quant Rating C · 42/100
1-year performance, rebased to 100
Microsoft edges it on the scoreable measures. Microsoft trades cheapest on trailing earnings; Microsoft pays the highest dividend yield; Microsoft earns the most per share.
| CRWD | MSFT | |
|---|---|---|
| Snapshot | ||
| Sector | Software - Infrastructure | Software - Infrastructure |
| Last price | 275.04 | 535.07 |
| Change today | +4.57% | +2.38% |
| 1-year return | +116.1% | +3.3% |
| Market cap | $281.62B | $3.97T |
| 52-week range | 85.68 – 286.99 | 348.54 – 549.20 |
| Valuation | ||
| P/E (TTM) | 7,237.89 | 29.81 |
| P/E percentile, own 5-yr range | 100th | 30th |
| P/B | 55.21 | 8.98 |
| Dividend yield | 0.00% | 0.67% |
| Profitability & growth | ||
| EPS (TTM) | -0.16 | 17.95 |
| Net profit (TTM) | $-166.90M | $133.29B |
| Revenue (TTM) | $5.40B | $331.84B |
| Revenue growth (YoY) | +25.8% | +17.7% |
| Gross margin | 75.2% | 67.9% |
| Operating margin | -2.5% | 46.8% |
| Net margin | 0.8% | 40.3% |
| Free cash flow (TTM) | $1.52B | $66.99B |
| Ownership & sentiment | ||
| Institutional ownership | 77.8% | 75.2% |
| Insider activity (12mo) | 6 buy / 44 sell | 31 buy / 16 sell |
| Short interest (% of float) | 2.6% | 0.8% |
| Analyst consensus | 86% buy / 14% hold (37) | 100% buy (34) |
| Analyst price target | $262 (-5%) | $594 (+11%) |
| StockVane view | ||
| StockVane Quant Rating | B (95) | C (42) |
| Company | ||
| Employees | 10,698 | 223,000 |
| Founded | 2011 | 1975 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.